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Anita Thapar, M.B.B.Ch., F.R.C.Psych., Ph.D., F.Med.Sci., ANDMiriam Cooper, M.B.Ch.B., M.R.C.Psych., B.Sc.opy number variation is now recognized
as an important class of risk factor forC several child psychiatric disorders. In this
article, we ﬁrst explain what copy number vari-
ants (CNVs) are. We then consider key ﬁndings
and what these have told us about the etiology of
these conditions. Finally, we discuss whether
these ﬁndings can yet translate into clinical
practice.
WHAT ARE COPY NUMBER VARIANTS?
There are multiple types of genetic alterations
that contribute to human variability, many of
which have yet to be fully characterized or
properly understood. This genetic variation can
involve differences in the DNA nucleotide se-
quence as well as changes in chromosome struc-
ture. Single nucleotide polymorphisms (SNPs) are
common variants of individual nucleotide se-
quence that are frequently observed in the pop-
ulation (>1%). CNVs are a type of structural
variant involving alterations in the number of
copies of speciﬁc regions of DNA, which can
either be deleted or duplicated. These chromo-
somal deletions and duplications involve fairly
large stretches of DNA (that is, thousands of
nucleotides [>1 kb], which may span many
different genes) but can range considerably in
size as well as prevalence. As is the case for other
types of genetic mutations, some CNVs are
inherited whereas others spontaneously arise de
novo. To date, most CNV research in psychiatry
has focused on rare forms of copy number vari-
ation that occur with a frequency of <1%.
WHAT ARE THE CNV FINDINGS FOR
CHILD PSYCHIATRIC DISORDERS?
There are several well-characterized rare de-
velopmental phenotypes caused by CNVs of
known pathogenicity, such as Velocardiofacial,JOURN
www.jaacap.orgPrader-Willi, and Smith-Magenis syndromes.
Although the role of most CNVs is far less
clear, there is now growing evidence that the
genetic architecture of more common psychiat-
ric and neurodevelopmental conditions includes
different types of both common and rare ge-
netic variation.1 An increased burden of rare
CNVs has been observed and replicated in
several conditions. These include autism spec-
trum disorder (ASD), attention-deﬁcit/hyper-
activity disorder (ADHD), and intellectual
disability (ID), as well as schizophrenia. CNVs
also contribute to risk of idiopathic epilepsy.
Risk factors for complex disorders tend to be of
small effect size (odds ratios of <2), and this has
certainly proved to be the case for individual
SNPs. Conversely, the types of CNVs that have
been found to be associated with neuro-
developmental and psychiatric disorders have
been of considerably greater effect size.2,3 This is
not surprising, because as the types of CNV mu-
tations that have been studied are so rare, their
effects have to be large to be detected in modest
sample sizes. In fact, so far large rare CNVs show
the strongest and most consistent associations,
and size and burden of CNVs seem to be pro-
portional to phenotypic severity. Large rare CNVs
appear to be further enriched in individuals who
have ASD or ADHD with comorbid ID,3,4 and
the burden appears to be even greater in those
with ID and congenital anomalies.2,3
Psychiatric disorders mainly have a complex,
multifactorial etiology. Apart from some infre-
quent exceptions (e.g., known genetic syndromes,
fetal alcohol syndrome, congenital rubella), a
single risk, whether genetic or environmental, is
neither necessary nor sufﬁcient to result in dis-
order. Thus, typical of all complex disease epi-
demiology, many carriers of risk CNVs will not
display a psychiatric or neurodevelopmental
phenotype, and not all those affected will possessAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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TRANSLATIONSthe risk variant. As an analogy, although cigarette
smoking is a well-established risk factor of large
effect size, not all smokers develop lung cancer,
and not all individuals with lung cancer have
smoked. There are likely multiple types of risks
and pathways that lead to the same child psy-
chiatric disorder.
WHAT HAVE CNV FINDINGS TOLD US?
CNV Mutations Can Arise De Novo
Genetic data from parents are required to identify
whether variants are inherited or have arisen de
novo. So far, although CNVs have been found to
be both inherited and de novo in origin, much
interest has focused on de novo mutations. Such
mutations are associated with risk of ASD, ID,
and schizophrenia but would not contribute to
the familial transmission of these disorders.
Increased paternal age has been found to be
associated with some types of mutations, as well
as with risks of both ASD and schizophrenia.
Rare de novo CNVs do not, however, necessarily
explain all the observed paternal age effect.
CNVs Span Traditional Diagnostic Boundaries
Although ASD, ADHD, schizophrenia, and ID
have clinically distinctive deﬁning features, one
key and consistent ﬁnding is that the CNVs
associated with each of these disorders show
signiﬁcant overlap with each other.1,5 That is,
the same CNV is associated with increased risk
of different types of disorders: this is known
as pleiotropy. This phenomenon is most consis-
tently observed for disorders considered to
have strong neurodevelopmental origins (ASD,
ADHD, schizophrenia, and ID). This observation
highlights that the same genetic risks operate
across diagnostic categories. That is also true for
other risk factors.
CNVs Can Provide Clues to Biology
The chromosomal regions that harbor CNVs
observed to be associated with psychiatric disor-
der are located at multiple genomic regions on
many different chromosomes, and each deletion
or duplication often encompasses several genes.
So, are these simply randomly distributed muta-
tions, or are their locations signiﬁcant? Multiple
types of evidence suggest that CNV locations
provide meaningful clues to the neurobiology of
these disorders. Genes code for proteins that are
involved in different biological processes. TheJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATR
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fully understood; however, genetic ﬁndings can
be used to make inferences about the biological
processes involved. Although there are some
methodological limitations to this approach,
consistent patterns of ﬁndings are emerging. The
rare CNVs found to be associated with ASD,
ADHD, schizophrenia, and ID all seem to span
genes that converge on meaningful biological
processes. For example, CNV studies of ASD,
schizophrenia, and ID have strongly implicated
disrupted synaptic function. Studies of ADHD
have suggested involvement of nicotinic acetyl-
choline receptor pathways, glutamatergic trans-
mission (also found in schizophrenia), and genes
involved in neural development.
WHAT ARE THE CLINICAL
IMPLICATIONS—AND WHAT NEXT?
To interpret CNV ﬁndings in a clinically mean-
ingful way is challenging. Essentially it is difﬁcult
to prove causal pathogenic effects. Moreover,
most child psychiatric disorders, including those
that have been found to be associated with CNVs,
are multifactorial in origin and not caused by a
single risk factor. In many cases, the presence of a
speciﬁc CNV will not necessarily imply that it
played a role in causing disorder, and, for some
CNVs, carriers can be unaffected. Inferring cau-
sality is further complicated by the high levels of
comorbidity between different child psychiatric
and developmental disorders. Furthermore, in-
complete penetrance, pleiotropic risk effects, and
de novo mutations make estimating the risk of
disorder recurrence particularly complex. The
etiological role of environmental factors and gene–
environment interplay in complex disorders
should also not be overlooked—nor should the
contribution of other classes of genetic variant.
Advances in techniques for detecting submi-
croscopic chromosomal abnormalities have
meant screening for rare CNVs in idiopathic ID
has become increasingly commonplace. Rare,
syndromic forms of ASD and other psychiatric
disorders will likely require similar types of
assessment and counseling. However, for most
children who are under the care of child psychi-
atrists, it seems unlikely that routine CNV test-
ing will become established practice in the near
future for the majority of individuals unless
perhaps they also have ID or multiple develop-
mental morbidities. Prevention and treatmentY
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THAPAR AND COOPERstrategies based directly on genetics also remain
distant.
Nonetheless, the establishment of CNVs as
risks for psychiatric disorders is an important
breakthrough. The ﬁndings highlight com-
monalities across different neurodevelopmental
disorders. The genes indexed by CNVs are
beginning to provide valuable biological insights
and clues to patterns of altered brain develop-
ment and function that accompany disorders
such as ASD, ADHD, and schizophrenia. CNV
ﬁndings, by shedding light on pathogenesis, can
contribute to progress in developing novel in-
terventions and risk modiﬁcation strategies that
target relevant risk processes in the nearer
future. &JOURNAL
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